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Background: Achieving the Millennium Development Goals (MDGs) and combating hotspots with escalating but
preventable communicable diseases remain major challenges in Africa. The European and Developing Countries
Clinical Trials Partnership (EDCTP) intervened to combat poverty-related diseases including malaria, tuberculosis and
HIV/AIDS, and to conduct multi-centre clinical trials and multi-disciplinary health research through an innovative
model of regional Networks of Excellence (NoEs).
Methods: We participated in a quasi-formative evaluation between October and December 2011 on the 4 regional-
led research networks. These included the: Central Africa Network on Tuberculosis, HIV/AIDS and Malaria (CANTAM);
East African Consortium for Clinical Research (EACCR); West African Network of Excellence for TB, AIDS and Malaria
(WANETAM), and the Trials of Excellence for Southern Africa (TESA) launched between 2009 and 2010. We shared a
participatory appraisal of field reports, progress reports and presentations from each network to jointly outline the
initial experiences of the merits, outputs and lessons learnt.
Results: The self-regulating democratic networks, with 64 institutions in 21 African countries, have trained over 1,
000 African scientists, upgraded 36 sites for clinical trials, leveraged additional € 24 million and generated 38 peer-
reviewed publications through networking and partnerships.
Conclusions: The shared initial merits and lessons learnt portray in part the strengthened capacity of these
networks for improved research coordination and conduct of planned multi-center clinical trials in Africa. Increased
funding by African agencies, governments and international health partners will ensure sustainability of these
networks for research capacity development and demonstrate their commitment to achieving the MDGs in Africa.
Keywords: Regional networks, Health, Clinical trials, Research, Capacity-building, AfricaBackground
The Millennium Development Goals (MDGs) are de-
scribed as ambitious for sub-Saharan Africa and are a
real barometer to assess countries' efforts towards im-
proving the health of populations [1]. These universal
goals target, among other priorities, poverty-related dis-
eases such as tuberculosis, malaria and HIV/AIDS. Al-
though Africa bears the greatest burden of these three
major diseases with potential for global transmission, the
continent is characterized by weak and under-resourced
health infrastructure, health interventions inappropriate* Correspondence: gmmiiro@yahoo.co.uk
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reproduction in any medium, provided the orto the scale of the problem, and benefits of health not
reaching those with the greatest disease burden [2,3]. In
addition, African health research institutions are crip-
pled by fragmentation, lack of coordination, diminishing
critical mass of qualified African researchers, inadequate
research infrastructure, and inconsistent and limited
funding opportunities [4,5]. Such challenges hamper the
contribution of African leadership to impact on research
about diseases of global health importance.
To address some of these challenges, the European
and Developing Countries Clinical Trials Partnership
(EDCTP), a European Union-funded and peer-review
grant awarding agency [6], initiated the concept of the
regional Networks of Excellence (NoEs) led by African
professionals [7] to champion capacity development,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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European member states while concurrently contribut-
ing to the MDGs. Some of the MDGs addressed by 2015
include MDG4: reducing child mortality; MDG6: combat-
ing HIV/AIDS, TB, malaria and other diseases, and
MDG8: developing global partnerships. Expected benefits
of the regional NoEs include: a) sustainable multi-site re-
search coordination and grant management capabilities, b)
generating capacity for up scaling the number of qualified
African scientists and health practitioners, c) securing in-
frastructure, partnerships and funds capable of responding
efficiently to regional diseases and threats through syn-
ergy and multi-disciplinary collaboration. The strategic
investment and contribution by the EDCTP to the four
NoEs (Figure 1) for the conduct of multi-centre clinicalFigure 1 Map of Africa showing the regional distribution and country
There are 64 institutions from 21 African countries within the 4 research netrials and health research in Africa deserves particular
appraisal [8].
The history and features of these networks are unique
[9]. How were the networks formulated? Which strat-
egies were developed by each network to achieve their
objectives? How have these networks interacted? And
finally what are some of the lessons learnt through
the NoEs’ programme? This joint introductory article
addresses some of these key questions. Detailed re-
sults from each NoE will be subsequently published
separately.
Methods
We participated in a quasi-formative evaluation of the
NoEs between October and December 2011 throughcomposition of the four. Regional Networks of Excellence. Legend:
tworks
Table 1 Countries, institutions, diseases and members of the Networks of Excellence (NoEs) programme
NoE (Project Coordinator)
# of institutions











University of Yaoundé I X X Rose Leke,
Veronique
Penlap
University of Buea X X Eric Achidi,
Peter Ndumbe
OCEAC X Parfait Awono
Congo University Marien Ngouabi X X X Francine
Ntoumi,
Obengui
CERVE X X Mathieu
Ndounga
Gabon Medical Research Unit of the Albert Schweitzer Hospital X X X Saadou
Issoufou
EACCR (Pontiano Kaleebu)
34 (represented here by 17
leading institutions
Sudan Institute of Endemic Diseases
(IEND), University of Khartoum
X X Mukhtar
Maowia
Ethiopia Armauer Hansen Research Institute (AHRI) X X Abraham
Aseffa






Medical Research Council (MRC)






X X Elly Katabira,
Andrew
Kambugu
Kenya Kenya Medical Research Institute








Kenya Medical Research Institute
(KEMRI)-Centre for Global Health Research in partnership with CDC
X X X Kayla Laserson
Kenya AIDS Vaccine Initiative
(KAVI)/University of Nairobi
X X Walter Jaoko,
Omu Anzala
Maseno University X Ayub Ofulla
Tanzania Kilimanjaro Christian Medical Centre (KCMC)/Kilimanjaro Clinical
Research Institute (KCRI)
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Table 1 Countries, institutions, diseases and members of the Networks of Excellence (NoEs) programme (Continued)
National Institute for Medical Research




Muhimbili University of Health and Allied Sciences X X X Eligius
Rwamuya,
Joyce Masalu





TESA (Alexander Pym) 10 Botswana Botswana Harvard HIV/AIDS Partnership (BHP) X X Rosemary
Musonda
South Africa South African Medical Research Council:
Tuberculosis Research Unit (TBRU)
X X Alexander Pym
Stellenbosch University Immunology
Research Group (SUN-IRG)
X X Gerhard Walzl
University of Cape-Town Lung Institute
(UCT-LUNG)
X Keertan Dheda




Zimbabwe University of Zimbabwe College of Health Sciences (UZ-CHS) X Lynn Zijenah
Biomedical Research and Training Institute (BRTI) X X Peter Mason
Zambia University of Zambia –University Teaching Hospital (UN-ZAM) X X X Peter Mwaba,
Duncan
Chanda
Malawi Malawi College of Medicine (Malawi- CoM) X X Newton
Kumwenda




Senegal Laboratory of Bacteriology-virology, A. Le Dantec Hospital (UCAD) X X Souleymane
Mboup
Institut Pasteur, Dakar X Aissatou Toure
The Gambia National Public Health Laboratories X Makei Taal




Project de Saude de Bandim X Paulo Rabna
Nigeria College of Medicine University of Ibadan X Aderemi
Kehinde
Nigerian Institute of Medical Research X Oni Idigbe
Innovative Biotech X Simon Agwale
Ghana Korle-bu Teaching Hospital University of
Ghana Medical School
X Audrey Forson
Noguchi Memorial Institute for Medical Research X Kwado Koram/
Nancy Duah









Centre Muraz X X Jean B
Ouedraogo/
Nicolas Meda
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retrospective review of field reports, meeting presenta-
tions and formal reports to EDCTP at the 6th EDCTP
forum [10]. We outline the experienced effects and
initial merits of the four African NoEs in terms of gov-
ernance, baseline studies, capacity building, networking,
research outputs, and ability to leverage further funding
under this newly introduced model.Results
We outline below the results of each network (NOE) by
the key reporting areas mentioned above.CANTAM (www.cantam.org)
A1. Project management
This West African-led network has 7 institutions from 3
African countries (Cameroon, Congo and Gabon, Table 1).
Its governance relies on a steering committee, with oneFigure 2 An example of laboratory refurbishment in Central Africa (U
University of Yaoundé I, given to CANTAM in 2009 (A1, A2), laboratory und
EDCTP/NACCAP funds (C1, C2) in 2011representative from each institution, responsible for all
crucial decisions. This steering committee appoints a
project coordinator at the secretariat in Congo who is
in charge of the daily management of the network,
assisted by two project managers from Gabon and
Cameroon.A2. Baseline studies
The sister institutions in Congo and Cameroon have de-
veloped assessment surveys, while Gabon plays a leading
role, with the Medical Research Unit in Lambaréné,
already conducting clinical trials on malaria. By combin-
ing initial baseline studies and senior fellowship projects
awarded to NoEs, CANTAM is better prepared to con-
duct future clinical trials in Cameroon (around Buea for
HIV/AIDS, in Yaounde and Mbalmayo for tuberculosis,
and in Niete and Mutengene for malaria) and Congo (all
sites are in Brazzaville).niversity of Yaoundé 1, Cameroon). Legend: Old laboratory of the
er renovation in 2009-2010 (B1, B2); and refurbished laboratory with
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Concerted effort has been put into capacity building:
laboratory upgrades (at the University Marien Ngouabi
and Makelekele hospital in Brazzaville, Congo and Buea
and Yaoundé I universities in Cameroon; Figure 2);
long –term training of masters, PhD, post-doctoral and
medical students and cross-cutting specific and short-
term courses, including grant writing, ethics and Good
Clinical Laboratory Practice (GCLP) (Table 2). Long-
term training and appropriate mentorships are essen-
tial, especially in Congo, where there is an acute short-
age of human resources in all disciplines [11].A4. Networking
CANTAM has developed relationships within its network,
and with local, regional and international organizations,
which have resulted into field mentorships, shared
training and joint seminars. Although North–south
partnerships are essential in education (via ‘sandwich’ PhD
programmes), technology transfer and joint grant writing,
special attention has also been given to South-South
partnerships, with emphasis on interactions with other
networks for complementarity, synergy and greater im-
pact. For example, EACCR facilitated short courses and
mentorships for about 10 CANTAM students.A5. Advocacy
EDCTP and CANTAM have been promoted through
publications, international conferences and meetings,
and networking with foreign and other organiza-
tions. Publications from CANTAM are increasing its
visibility [11,12]. In Congo, Cameroon, and very re-
cently in Gabon, EDCTP site visits were excellent
opportunities for high-level advocacy and resource
mobilization among prime ministers, ministers of
higher education and of public health from each
country.Table 2 Selected outputs from the Networks of Excellence (N








CANTAM 83 - 6 8 - 4
EACCR 169 - 24 - - 4
TESA 539 3 12 5 3 2
WANETAM 175 - 2 1 - 2
Total 966 3 44 14 3 12
* these include: GCP, GCLP, laboratory techniques, IT, ethics, grant writing, epidemi
parasitology and entomology.
** these are EDCTP sponsored senior fellowships which are affiliated to the NoEs.
# Selected publications have been referenced below due to space considerations bA6. Funding
CANTAM received initial funding of € 2,997,644 from
the EDCTP and Netherlands-African Partnership for
Capacity development and Clinical interventions Against
Poverty-related diseases (NACCAP). Through the EDCTP,
additional funding has been awarded to CANTAM-
affiliated institutions, including three senior fellowships
linked to NoEs, a re-entry grant, and two grants for bio-
ethics and regulatory strengthening. In addition, Total
Congo agreed to support research on malaria and severe
diarrhea. Paraxel plans to conduct a clinical trial in one of
CANTAM's malaria sites in Cameroon. Finally, an
EDCTP-sponsored clinical trial is being conducted in
Gabon as an integrated project on malaria. Overall,
CANTAM received € 5,238,000, including additional
funds leveraged, for preparing clinical trial sites and
conducting clinical research/trials, of which 78% is from
EDCTP (Table 2).EACCR (www.eaccr.org)
B1. Project management
This East African-led network has 34 regional institu-
tions from Kenya, Tanzania, Uganda, Sudan and Ethiopia
(Figure 1, Table 1) and 7 northern partners from Europe.
Governance is structured regionally into 4 coordinating
centers (nodes): malaria (Kenya), TB (Tanzania), HIV
(Uganda) and training (Tanzania), which report to the
overall project coordinator. The coordinator reports to
an independent steering committee (with directors of
leading regional institutions and representatives of north-
ern partners) and to EDCTP. Meetings occur regularly
through teleconferences, and face-to-face interaction.B2. Baseline studies
Nodes conducted site assessment surveys on existing
regional capabilities for training/mentoring and also pri-
oritized infrastructural upgrades among 17 sister institu-













ology, biostatistics, molecular biology, immunology, public health, clinical trials,
ut the full list of all publications is available on request.
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Short-term training
Four accessible user-friendly electronic learning research
modules were developed and uploaded onto the EACCR
website in partnership with the University of Oxford,
Global Health Trials, World-Wide Anti-malarial Resist-
ance Network (WWARN), and the Bill and Melinda
Gates Foundation. Plans are underway to translate the
modules into French for improved accessibility and
greater impact. EACCR also conducted short courses in
epidemiology, medical statistics, clinical trial monitoring
and tropical immunology in partnership with the
London School of Hygiene and Tropical Medicine
(LSHTM), University of Cambridge and the Wellcome
Trust (Table 2). Thus, regular courses are available at a
highly subsidized fee or through partial competitive
scholarships.
Long-term training
Four competitive EDCTP senior-fellowships were se-
cured for promising research in Malaria (1), TB (1) and
HIV/AIDS (2) between November 2009 and November
2010. In addition, 24 masters research fellowships have
been sponsored (Table 2), 7 of which are pursued online.
Reciprocal clinical monitoring scheme
More than 20 regional monitors are conducting cross-
site paired mentoring visits using standardized operating
procedures. Shared best clinical monitoring practices are
observed by new/upcoming monitors paired to experi-
enced monitors [13]. Consultancy services are available
at a negotiable fee for tailored trial training and mo-
nitoring.
B4. Networking
Participatory evaluation of the quality and bioethics of 2
research-monitoring schemes in East Africa and Asia is
underway in partnership with WWARN and LSHTM.
Furthermore, three EACCR’s fellows on masters de-
gree training secured more research funding through
highly competitive scholarships from a Wellcome Trust
Consortium-Training Health Researchers in Vocational
Excellence THRiVE (www.thrive.or.ug).
B5. Advocacy
EACCR members shared thirty scientific presentations
and abstracts at international meetings. This group
interacted with other consortia such as Tuberculosis
Vaccine Trials in Europe and Africa, TB-TEA (www.
mpiib-berlin.mpg.de), CANTAM and THRiVE. In
addition, contacts were initiated with policy-makers of
the East African Community by EDCTP [14].B6. Funding
EACCR is funded by EDCTP with co-funding from
NACCAP and the Medical Research Council-United
Kingdom (MRC-UK) at a level of € 3.5 million. About
€ 1.4 million in additional funds have been leveraged
from other sources, such as Global Health Trials,
WWARN, Wellcome Trust and the International Associ-
ation of National Public Health Institutes (Table 2). To sus-
tain its activities, this network has submitted for funding at
least 5 collaborative grants on research coordination, HIV
prevention research, and rapid TB diagnostics.
TESA (www.tesafrica.org)
C1. Project management
This South African–led network has 10 institutions across
6 countries including Botswana, Malawi, Mozambique,
South Africa, Zambia and Zimbabwe, supported by
the EDCTP through the South African Medical Re-
search Council (SA-MRC) TB Research Unit. TESA
currently supports, on a part- or full- time basis, be-
tween 40–50 scientists, clinicians, nurses and labora-
tory technologists.
C2. Baseline studies
Through the network’s capacity development strategy,
TESA-network institutions have initiated several HIV,
TB and malaria studies (some of which have been pub-
lished [15-22]), either at individual sites or jointly within
multiple sites. These studies include:
 Changes in plasma cytokine levels over time during
chronic asymptomatic HIV-1c Infection, an
indicator of disease progression
 Rifaquin trial in newly diagnosed TB cases,
Pharmaco-Kinetic studies, and molecular studies
using isolates from cases of treatment failure or re-
infection, and suspected multi-drug resistant-TB
[16,18,20]
 HIV-1 incidence rate among patients with sexually
transmitted infections
 Diagnostic and biomarker studies in those patients
with suspected TB
 Epidemiological, microbiological, clinical and socio-
economic studies of re-treated TB patients
 Intensive case finding to determine the prevalence
of drug sensitive and resistant-TB among those
patients with suspected TB
 Accuracy and impact studies of Gene Xpert and
newer diagnostic techniques including the
urinary lipoarabinomannan strip test
[15,17,19,21]
 Studies about the burgeoning drug-resistant TB
epidemic and therapeutically destitute cases of drug
resistant TB
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Following advertisement of courses on the TESA web-
site, trainees and students were selected based on the in-
stitutions’ internal training policies, research projects
and availability of research grants. Within the past two
years more than 500 clinical research staff affiliated to
TESA received short-courses training in internal
auditing and quality control, International Air Transport
Association-IATA training, HIV, TB and malaria labora-
tory diagnostic techniques, and methodological courses
including the epidemiological, clinical and operational
research course; qualitative research methods course; in-
formation technology, software training; workshops on
Good Clinical Practices and bioethics; and seminars on
scientific and grant writing skills, and biostatistics
(Table 2).
As part of TESA’s long-term capacity development
program, 25 scientists are studying in various univer-
sities at masters, PhD and post-doctoral level (Table 2).
Three TB, HIV and malaria laboratories within TESA
institutions have been accredited and a further three
laboratories are in the process of accreditation. Two
research training facilities and one clinical research
site have been upgraded and most laboratories were
refurbished with basic equipment and information tech-
nology support systems.
C4. Networking
The networking within TESA has taken various forms
including, i) student visits and attendance in cross coun-
try courses, ii) scientific presentations at national and
international conferences and forums iii) attendance of
regular national and regional technical meetings by in-
vestigators with the national departments of health, sci-
ence councils, and academia, iv) linkages with national
regulatory authorities and v) liaisons with European sci-
ence councils, pharmaceuticals, donors and funding
agencies.
C5. Advocacy
The design and operationalization of the TESA Website
in May 2010 facilitated above networking activities,
communication and circulation of information about ac-
tivities and courses, and linkage with international
organizations.C6. Funding
TESA received € 2.3 million in November 2009 from
EDCTP, followed by additional in-kind contribution of €
280,000 from SA-MRC. However, most TESA sites have
since developed new research proposals, which to date
have attracted an additional ~ € 20 million in research
grants and contracts (Table 2).WANETAM (www.edctp.org/project_profiles.245.0.html)
D1. Project management
WANETAM established 6 Work Packages (project man-
agement, training, networking, HIV-related training and
survey, TB-related training and survey, and malaria re-
lated training and survey). Work package leaders and
the project manager constituted the steering committee,
chaired by the project coordinator. This committee
meets every other month by teleconference to review
progress in capacity-building and training. The coordin-
ator is responsible for submitting annual technical and
expenditure reports to the EDCTP. The responsibility
for individual projects (resources, research and meeting
milestones) was devolved to site Principal Investigators,
who interact directly with Work Package leaders to pro-
duce written reports. WANETAM also has an independ-
ent advisory board, whose role is to advise the steering
committee on the evolution of important activities.
D2. Baseline studies
WANETAM did not initially include baseline studies.
However, through the second annual meeting, submis-
sion of a revised work plan for year 3 and the subse-
quent re-allocation of funds, the principal investigators
agreed to carry out HIV/AIDS, tuberculosis, and malaria
baseline surveys as a sustainability strategy.
D3. Capacity building
From January 2011 to June 2011 WANETAM trained
175 West African junior and senior scientists in clinical
trial-related topics (Table 2) and disease-specific labora-
tory training organized by different partner institu-
tions. Moreover, laboratories at Korle-bu (Ghana), and
Guinea-Bissau have been refurbished. Specific equip-
ment has been purchased for TB-associated laboratories
while other laboratories have received equipment for
hematology or biochemistry studies.
D4. Networking
The secretariat has hosted two annual meetings of the
principal investigators, which addressed the critical chal-
lenges that WANETAM has encountered (such as the
initial omission of baseline studies and sustainability).
The group has also established exchange and mentorship
programmes between institutions. Additional network-
ing has led to more funding through WANETAM Plus
(constituted by WANETAM-TB institutions plus other
institutions from Benin, Mali and Burkina Faso), and
WAPHIR (West African Platform for HIV Intervention).
Furthermore, joint study proposals have been submit-
ted to the Trilateral Initiative (Germany, France, and
WANETAM), and Framework Programme 7 of the
European Commission grant call.
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WANETAM created an efficient and reliable communica-
tion environment. Through a web-based platform called
Basecamp, members can share information of interest,
work on the same document, and discuss activities
of the consortium (https://wanetamproject.basecamphq.
com). Recently, the consortium has implemented a Voice
on IP teleconference system allowing free communication
among the partners. Prior to this, WANETAM created its
website which is open to the public. In addition to the
above communication strategies, WANETAM distributes
regular newsletters.
D6. Funding
Overall, the EDCTP contributed € 3,499,921. Of this,
NACCAP, MRC-UK, and MRC-Gambia contributed
€ 1,000,000, € 406,000, and € 300,000 respectively.
Discussion
The 4 NoEs described above, with 64 institutions from
21 African countries are African-led, multi-disciplinary,
and multi-disease-oriented (Figure 1, Table 1). They are
comparable to the subsequent Wellcome Trust initiative
comprising 7 consortia which interlink 52 institutions
from 18 African countries [23,24]. In contrast, the
Malaria Capacity Development Consortium, Multilateral
Initiative on Malaria and the ALPHA network have a
single-disease orientation [25-27].
Robust and democratic governance structures are
essential for the success of such networks [24]. The
EDCTP NoEs have created described governance struc-
tures for self-regulation. The initial achievements and
lessons learnt are discussed below. It is challenging to
devise generic indicators for monitoring and evaluating
capacity building since each project is unique [28]. Like
other consortia [25-27], we predominantly referred to
initial output-based (lower process) indicators from a
donor reporting format such as number of fellowships
sponsored, number of participants trained (Table 2), and
number of facilities upgraded. We also attempted to in-
clude higher outcome indicators [5,25,27,28] such as
amount of additional funds leveraged from alternative
sources and number of publications. Over time, we shall
track and include the number of PhD and doctoral fel-
lows retained in Africa, and the number of policy out-
comes. This paper contributes to further discussion of
suitable indicators of progress for inclusion in subse-
quent monitoring and evaluation initiatives.
Project management
Each network has a governance structure for better re-
search coordination and resource sharing across Anglo-
phone, Lusophone and Francophone countries in Africa.
Another distinct feature of these NoEs is thatconsultative strategic planning processes were self-led
rather than being dictated by the EDCTP. Thus, each
NoE and partner institutions had the flexibility to adopt
appropriate research capacity development activities well
aligned to their preferences.
Baseline studies
The NoEs opted to conduct baseline studies for two
main reasons linked to sustainability strategies. First,
they constitute a practical prerequisite for the conduct
of clinical trials in future. Second, in terms of visibility,
these studies are publishable aspects of the research ac-
tivities for each NoE.
Capacity building
NoEs have invested substantially in clinical trial infra-
structure and in education, through specific or crosscut-
ting short-term training, long-term training, and/or field
mentorships to produce networked high-skilled African
researchers. Stronger research institutions have been
coupled with upcoming ones for on-going mentoring.
However, results will take years to be measured, espe-
cially in Central Africa, where a critical mass of scien-
tists is nascent and the culture of research is still
dramatically lacking. Some NoEs experienced challenges
in grant management, including inadequate prior estab-
lishment of monitoring and evaluation systems and
delayed disbursement of funds. For instance, it was ex-
tremely difficult for EACCR to disburse funds to Sudan,
possibly because of political concerns there. Some ob-
served gaps in grant management should be filled with
additional training and technical assistance in project
and financial management.
Networking
First, institutions within each NoE have learnt to collab-
orate in joint proposal development and project imple-
mentation, including budget sharing while avoiding
duplication of effort. Second, regional NoEs have devel-
oped enriching relationships among themselves. EACCR
welcomed CANTAM students and staff for short-term
training on several occasions, thus reinforcing the links
between institutions from the different NoEs. However,
more initiatives engaging all the four NoEs should be en-
couraged. Third, all NoEs have interacted with various
networks, organizations or northern partners, including
WWARN, Global Health Trials, THRiVE, Initiative to
Strengthen Research Capacity in Africa, Africa AIDS
Vaccine Partnership and the African Network on Drugs
and Diagnostics Innovation among others. More import-
antly and for purposes of sustainability, the networks are
strongly encouraged to engage the policy-makers and
the pharmaceutical industry to: inform policies and
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practices and interventions [4,5,29-32].
Advocacy
All four NoEs created their own websites to strengthen
communication, interaction, advertising of training oppor-
tunities, sharing of pictures related to specific activities of
the networks, and listing publications derived from re-
search activities. Publications in peer-reviewed journals
derived from baseline studies will enable each NoE to gain
more visibility and credibility for sustainability.
However, frequent Internet disconnections are challen-
ging. Communication can be improved through better
Internet connectivity as recently developed by WANETAM
and through more efficient video conferencing and webinar
series.
Funding
The networks have made concerted effort to leverage
additional funds from alternative sources for their sus-
tainability. TESA has performed superbly in attracting a
10-fold increase in additional funds from the baseline
grant awarded by the EDCTP. Other networks are en-
couraged to emulate this sustainability strategy.
Conclusion
The most rewarding experience emerging from this ini-
tiative is that the 4 networks have great potential to con-
tribute synergistically to the attainment of the MDG 4,
6, and 8 in Africa, which focus on reduction of child
mortality, combating HIV/AIDS, malaria, and other dis-
eases for development as emphasized by a similar initia-
tive by Wellcome Trust [24,29]. For sustainability, the
NoEs recommend i) financing of streamlined career
pathways, such as re-entry grant fellowships and com-
petitive scientific awards for productive retention of
young and promising African scientists, and ii) increased
financial support from the African funding agencies and
African governments [5,29-32] in the context of coun-
try– and regional-owned initiatives to facilitate faster
progress towards achieving the MDGs on the continent.
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